Immunologically, AD is driven by a predominant type 2 helper (Th2) cell response, involving the release of cytokines like IL-4, IL-5, and IL-13 that promote IgE synthesis and eosinophilic inflammation. Here, IGHE is linked to Alzheimer disease.